Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
Between March 2019 and March 2020, Aster DM Healthcare's total assets increased from ₹8,928 crore to ₹12,405 crore. This growth was accompanied by an increase in total liabilities from ₹8,928 crore to ₹12,405 crore. Notably, borrowings rose significantly from ₹2,788 crore to ₹5,605 crore, while fixed assets grew from ₹4,289 crore to ₹7,124 crore. Equity capital saw a slight decrease from ₹505 crore to ₹497 crore, while reserves increased from ₹2,709 crore to ₹2,775 crore.
Aster DM Healthcare's cash flow from operating activities more than doubled from ₹601 crore in the year ended March 2019 to ₹1,223 crore in the year ended March 2020. Consequently, free cash flow also saw a substantial increase, rising from ₹64 crore in March 2019 to ₹715 crore in March 2020. The company's cash flow from financing activities shifted from a positive ₹134 crore in March 2019 to a negative ₹675 crore in March 2020.
In September 2026, ICRA upgraded the long-term credit rating of KIMS Healthcare Management Limited (KHML), a material subsidiary of Aster DM Quality Care Limited, to [ICRA]AA (Stable) from [ICRA]AA-. This upgrade was attributed to the improved credit profile of the parent company following a merger. Separately, on August 31, 2026, Aster DM Quality Care Limited announced a plan to add approximately 184 beds to its Trivandrum facility by May 2028, requiring an investment of ₹1.344 billion, to be financed by 70% debt and 30% equity.
On September 2, 2026, Union (Mauritius) Holdings Ltd., part of the Dr. Azad Moopen family, acquired 46.09 lakh equity shares of Aster DM Quality Care Limited from Centella Mauritius Holdings Limited for approximately ₹350.34 crore. This transaction, at a price of ₹760 per share, increased the promoter group's stake by about 0.57%, bringing their total holding to 24.58%.
As of September 18, 2026, the daily trend indicators for Aster DM Healthcare show a closing price of ₹755.05. The 14-day ADX is 19.82, with the minus DI at 24.68 and the plus DI at 18.29, suggesting a weakening trend. The Supertrend is bearish at ₹797.85. In contrast, the monthly trend indicators are bullish, with the 14-day ADX at 32.14, minus DI at 10.15, and plus DI at 28.76. The Supertrend on a monthly basis is bullish at ₹535.05.
As of 18 Sept 2026, 03:30 pm
Recent drawdown and price variability remain within the producer's contained-risk thresholds.
Primary driver: Price swings are higher than typical
Upward price movement of 2.61 standard deviations recorded on 2026-09-03.
Unusual market activity that may warrant review of the underlying price, volume, or news context.
Trading volume was unusually high, but the closing price did not show a clear directional move.
This indicates increased participation without a clear directional signal.
Downward price movement of 2.89 standard deviations recorded on 2026-08-20.
Unusual market activity that may warrant review of the underlying price, volume, or news context.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹1,310.68 crore | ₹1,182.38 crore | ₹1,185.76 crore | ₹1,197.21 crore | ₹1,077.87 crore |
| Finance Costs | ₹31.21 crore | ₹29.99 crore | PEAK₹31.46 crore | ₹30.76 crore | ₹30.77 crore |
| Expenses | PEAK₹1,146.86 crore | ₹1,047.03 crore | ₹1,073.64 crore | ₹1,044.25 crore | ₹964.50 crore |
| Exceptional Items Before Tax | -₹114.38 crore | PEAK₹33 lakh | -₹28.29 crore | -₹36 lakh | -₹4.39 crore |
| Profit Before Tax | ₹86.47 crore | ₹171.88 crore | ₹111.80 crore | PEAK₹180.85 crore | ₹142.16 crore |
| Tax Expense | PEAK₹48.80 crore | ₹9.77 crore | ₹44.40 crore | ₹45.54 crore | ₹42.88 crore |
Aster DM Quality Care reported revenue of ₹1,310.68 crore for the first quarter of FY2026-27, up 21.6% from the same period last year. Reported net profit fell to ₹29.28 crore, driven by a ₹114.38 crore exceptional charge. Excluding this item, profit before tax grew 37.0% year-on-year, showing that underlying earnings expanded despite the one-time deduction.
Revenue from operations reached ₹1,310.68 crore, the highest level in the available five-quarter series. This represents a 10.85% increase from the preceding March quarter and a 21.6% increase from the year-ago quarter. Revenue has varied across recent quarters, ranging from ₹1,077.87 crore to ₹1,197.21 crore, before rising in the current period.
Total expenses rose 9.53% sequentially and 18.91% year-on-year to ₹1,146.86 crore. Revenue growth exceeded expense growth in both comparisons. Consequently, the ratio of expenses to revenue decreased from 88.6% in the March quarter to 87.5% in the current quarter.
Segment revenue matched total revenue at ₹1,310.68 crore. Segment profit before tax was ₹78.08 crore, down 52.2% sequentially and 42.8% year-on-year from the prior quarter and year-ago quarter, respectively. The segment result includes the impact of the exceptional charge. Reported profit before tax exceeded segment profit before tax by ₹8.39 crore, reflecting unallocated corporate-level items.
Aster DM Quality Care delivered top-line growth in the June quarter, with revenue reaching a five-quarter high. Reported net profit was heavily impacted by a ₹114.38 crore exceptional charge, which reduced bottom-line earnings by nearly two-thirds compared to the prior year. Underlying profit before tax, however, expanded by 37.0% year-on-year, demonstrating that core operational earnings grew despite the one-time deduction.
Exchange disclosures and regulatory announcements for Aster DM Healthcare.
ICRA upgraded the long-term credit rating of KIMS Healthcare Management Limited (KHML), a material subsidiary of Aster DM Quality Care Limited, to [ICRA]AA (Stable) from [ICRA]AA-, and reaffirmed its short-term rating at [ICRA]A1+, removing the ratings from Rating Watch with Developing Implications. The upgrade reflects the improved credit profile of its parent, Aster DM Quality Care Limited, following the successful merger of Quality Care India Limited with Aster DM Healthcare Limited. KHML's revenue grew approximately 23% in FY2026, and its operating margin improved to 30.2% from 26.2% in FY2025, with total debt/OPBDITA at 0.4 times as of March 31, 2026.
On August 31, 2026, Aster DM Quality Care Limited announced a proposal to add approximately 184 beds to its existing ~795-bed facility by May 2028 through the construction of the KIMSHEALTH New Block. The company requires an investment of INR 1.344 billion for this expansion, which will be financed with 70% debt and 30% equity. This initiative aims to address space constraints, expand key specialties, and strengthen healthcare infrastructure in Trivandrum.
Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 to BSE and NSE on September 4, 2026. The report covers consolidated operations from April 1, 2025, to March 31, 2026, with independent reasonable assurance provided by BDO India Services Private Limited on non-financial core indicators. Key disclosed outcomes include sourcing 30% of electricity from renewable energy, avoiding over 16,000 tonnes of CO2e emissions, and benefiting 1.24 million individuals through social initiatives.
Multiple companies, including Aster DM Quality Care Limited, The Rajagiri Rubber and Produce Company Limited, LJ International Limited, Nile Limited, Anka India Limited, JMJ Fintech Limited, Wallfort Financial Services Limited, and Ovobel Foods Limited, have issued notices for their Annual General Meetings scheduled between September 25 and September 30, 2026. These filings confirm that meetings will be conducted via Video Conferencing or Other Audio-Visual Means with remote e-voting facilities provided by NSDL or CDSL, with specific cut-off dates for voting eligibility ranging from September 18 to September 23, 2026. Additionally, LJ International Limited disclosed a recommended dividend of Rs. 5/- per equity share (50%) for the financial year 2025-26, subject to shareholder approval at its AGM on September 29, 2026.
On September 2, 2026, Union (Mauritius) Holdings Ltd., owned by Dr. Azad Moopen and family, acquired 46.09 lakh equity shares of Aster DM Quality Care Limited from TPG-backed Centella Mauritius Holdings Limited for an aggregate consideration of approximately ₹350.34 crore at ₹760 per share. This transaction increased the promoter group's stake in the company by approximately 0.57%, raising their total holding to 24.58%.
ASTER DM QUALITY CARE LIMITED will hold its 18th Annual General Meeting on September 28, 2026, in Hyderabad to adopt audited financial statements for the year ended March 31, 2026, and re-appoint Mr. Thadathil Joseph Wilson as a Non-Executive Non-Independent Director. The meeting includes resolutions to ratify remuneration for Cost Auditors for FY 2026-27 and increase lending limits to subsidiaries from ₹1,500 Crore to ₹7,500 Crore under Section 185 of the Companies Act, 2013. Additionally, shareholders are set to vote on a special resolution to raise the aggregate investment and loan limit from ₹11,500 Crore to ₹18,800 Crore under Section 186.
Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) is holding its 18th Annual General Meeting on 28 September 2026 via video conferencing to adopt audited financial statements for FY ended 31 March 2026, re-appoint director T J Wilson, ratify cost auditor remuneration of INR 2,75,000 for FY ending 31 March 2027, and seek special resolutions to increase loan/guarantee/security limits under Section 185 to INR 7,500 Crores and under Section 186 to INR 18,800 Crores, following the merger with Quality Care India Limited effective 1 July 2026.
Recent market and company developments associated with Aster DM Healthcare.
MF holding, August
Discover high-conviction stock picks that analysts believe could yield significant returns amid market volatility. This article highlights five large-cap stocks and nine mid/small caps, detailing their target prices and potential upside.
business news live, ipo, gmp, gold, silver, oil price, india
Advent International and Blackstone-backed Aster DM Quality Care are negotiating to acquire a controlling stake in Yatharth Hospitals and Trauma Care Services, a listed, north India-centric, specialty hospital chain, said people with knowledge of the matter.
Aster, advent, yatharth hospitals, yatharth hospitals sale
Some Nifty 500 stocks rallied as others slipped on reasons including crude oil's extended rise. Here's a look at today's top gainers and losers at market open
Aster DM Quality Care news,Aster DM Quality Care bulk deals
On Tuesday, August 18, CNBC-TV18 reported that Centella Mauritius Holdings was likely to sell 7.2% stake in Aster DM Quality Care, formerly known as Aster DM Healthcare, via a block deal worth around ₹4,780 crore.
Comprehensive Section Breakdown for Aster DM Healthcare
Strategic Vision: Integrated healthcare provider operating hospitals, pharmacies, and diagnostic centres.
• Integrated healthcare network
• Strategic presence in non-metro cities
Reported profit before tax declined to ₹86.47 crore, falling 49.7% sequentially and 39.2% year-on-year. The decline was primarily due to an exceptional item before tax of -₹114.38 crore, a notable departure from the ₹0.33 crore gain in the prior quarter and the -₹4.39 crore charge in the year-ago quarter. After a tax expense of ₹48.80 crore, net profit dropped 80.9% sequentially and 68.7% year-on-year to ₹29.28 crore.
When adjusted for the exceptional charge, profit before tax would have been ₹200.85 crore. This figure is 17.1% higher than the March quarter’s adjusted level of ₹171.55 crore and 37.0% higher than the year-ago quarter’s adjusted level of ₹146.55 crore.
Aster DM Quality Care reported a strong combined proforma Q1 FY27, with revenue up 20% YoY to INR 2,597 Cr and operating EBITDA up 30% to INR 576 Cr, led by higher patient volumes, improved ARPP IP (+10%), and effective cost management. The merger, effective July 1, 2026, created a network of 39 hospitals across 28 cities with over 10,800 beds, positioning it among India's top three hospital chains.
Management outlined a strategic roadmap: expand bed capacity to over 15,000, unlock 10-15% EBITDA synergies from integration and procurement, and continue leveraging clinical excellence and technology. Kasargod's rapid breakeven and strong specialty growth in oncology, neuroscience, and medical value travel (+62% YoY) underscore demand and operational momentum.
Category: Healthcare Services
Operates a network of hospitals across multiple Indian states, with plans for significant bed capacity expansion.
Key Products & Services: Aster Medcity • Aster MIMS • Aster Whitefield • Aster Aadhar Hospital • Prime Hospitals
Category: Retail
Provides pharmacy services as part of its integrated healthcare network.
Category: Healthcare Services
Operates diagnostic centres as part of its integrated healthcare network.
Core Thesis: The company leverages an integrated healthcare network to enhance reach and service delivery across various Indian cities.
• Network Expansion: The company is focused on expanding its hospital footprint, particularly in Tier II and III cities, through brownfield and greenfield projects. • Capacity Enhancement: Aims to add approximately 1,700 beds by FY27, increasing total bed capacity in India to around 6,600. • Geographic Diversification: Strategically distributes its network across multiple states, including Kerala, Karnataka, Andhra Pradesh, Maharashtra, and Telangana.